Caricamento...
Modified metformin as a more potent anticancer drug: Mitochondrial inhibition, redox signaling, antiproliferative effects and future EPR studies
Metformin, one of the most widely prescribed antidiabetic drugs in the world is being repurposed as a potential drug in cancer treatment. Epidemiological studies suggest that metformin exerts anticancer effects in diabetic patients with pancreatic cancer. However, at typical antidiabetic doses the b...
Salvato in:
| Pubblicato in: | Cell Biochem Biophys |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5680142/ https://ncbi.nlm.nih.gov/pubmed/28429253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12013-017-0796-3 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|